Literature DB >> 10622732

Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships.

E Sergediene1, K Jönsson, H Szymusiak, B Tyrakowska, I M Rietjens, N Cenas.   

Abstract

Polyphenolic antioxidants exhibited a dose-dependent toxicity against human promyelocytic leukemia cells (HL-60). Their action was accompanied by malondialdehyde formation, and was partly prevented by desferrioxamine and the antioxidant N,N'-diphenyl-p-phenylene diamine. This points to a prooxidant character of their cytotoxicity. A quantitative structure-activity relationship (QSAR) has been obtained to describe the cytotoxicity of 13 polyphenolic antioxidants belonging to three different groups (flavonoids, derivatives of gallic and caffeic acid): log cL50 (microM) = (2.7829+/-0.2339)+(1.2734+/-0.4715) Ep/2 (V)-(0.3438+/-0.0582) log P (r2 = 0.8129), where cL50 represents the concentration for 50% cell survival, Ep/2 represents the voltammetric midpoint potential, and P represents the octanol/water partition coefficient. Analogous QSARs were obtained using enthalpies of single-electron oxidation of these compounds, obtained by quantum-mechanical calculations. These findings clearly point to two important characteristics determining polyphenol cytotoxicity, namely their ease of oxidation and their lipophilicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622732     DOI: 10.1016/s0014-5793(99)01561-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Polyphenols: skin photoprotection and inhibition of photocarcinogenesis.

Authors:  F Afaq; S K Katiyar
Journal:  Mini Rev Med Chem       Date:  2011-12       Impact factor: 3.862

2.  Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line.

Authors:  N Rajendra Prasad; A Karthikeyan; S Karthikeyan; Bandugula Venkata Reddy
Journal:  Mol Cell Biochem       Date:  2010-11-30       Impact factor: 3.396

3.  Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.

Authors:  Hyo Jin Son; Ji Hyun Choi; Ji Ae Lee; Dong Jin Kim; Kye Jung Shin; Onyou Hwang
Journal:  J Mol Neurosci       Date:  2015-02-22       Impact factor: 3.444

4.  [Experimental model for treating pulmonary metastatic melanoma using grape-seed extract, red wine and ethanol].

Authors:  Cristina Martínez Conesa; Vicente Vicente Ortega; M Josefa Yáñez Gascón; Juana Maria García Reverte; Manuel Canteras Jordana; Miguel Alcaraz Baños
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

Review 5.  Density functional theory studies of the antioxidants-a review.

Authors:  Samira Mahmoudi; Mehrdad Mohammadpour Dehkordi; Mohammad Hossein Asgarshamsi
Journal:  J Mol Model       Date:  2021-08-31       Impact factor: 1.810

Review 6.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 7.  Exogenous antioxidants--Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses.

Authors:  Jaouad Bouayed; Torsten Bohn
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

8.  Quantitative structure-antioxidant activity relationships of flavonoid compounds.

Authors:  Orsolya Farkas; Judit Jakus; Károly Héberger
Journal:  Molecules       Date:  2004-12-31       Impact factor: 4.411

9.  Phenolic esters with potential anticancer activity--the structural variable.

Authors:  Nelson F L Machado; Rita Calheiros; Sónia M Fiuza; Fernanda Borges; Alexandra Gaspar; Jorge Garrido; Maria P Marques
Journal:  J Mol Model       Date:  2007-03-06       Impact factor: 1.810

10.  Towards modernization of the formulation of the traditional uighur medicine herbal preparation abnormal savda munziq.

Authors:  Murat Kizaibek; Ruxandra Popescu; Sonja Prinz; Halmurat Upur; Judith Singhuber; Martin Zehl; Brigitte Kopp
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.